9267
Genky DrugStores Co.,Ltd.
Genky DrugStores
- Industry
- Retail Trade
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Stock adjustmentsJun 21, 2024 Stock split 1 share → 2 shares
Key metrics
Revenue(million JPY)
Jun 2022
154,640
Jun 2023
169,059
Jun 2024
184,860
Jun 2025
200,786
Jun 2026
220,638
Operating profit(million JPY)
Jun 2022
5,675
Jun 2023
6,709
Jun 2024
9,015
Jun 2025
9,658
Jun 2026
10,985
Operating profit margin(%)
Jun 2022
3.67
Jun 2023
3.97
Jun 2024
4.88
Jun 2025
4.81
Jun 2026
4.98
Profit before tax(million JPY)
Jun 2022
6,084
Jun 2023
6,704
Jun 2024
8,803
Jun 2025
9,902
Jun 2026
11,153
Profit(million JPY)
Jun 2022
4,421
Jun 2023
4,764
Jun 2024
6,324
Jun 2025
7,066
Jun 2026
7,875
Total assets(million JPY)
Jun 2022
97,118
Jun 2023
105,912
Jun 2024
113,939
Jun 2025
127,326
Jun 2026
145,598
Cash and cash equivalents(million JPY)
Jun 2022
5,438
Jun 2023
5,329
Jun 2024
5,896
Jun 2025
6,221
Jun 2026
7,866
Cash flows from operating activities(million JPY)
Jun 2022
6,076
Jun 2023
8,773
Jun 2024
13,256
Jun 2025
12,597
Jun 2026
16,975
Cash flows from investing activities(million JPY)
Jun 2022
-10,589
Jun 2023
-9,736
Jun 2024
-10,631
Jun 2025
-15,618
Jun 2026
-20,278
Cash flows from financing activities(million JPY)
Jun 2022
2,038
Jun 2023
854
Jun 2024
-2,058
Jun 2025
3,346
Jun 2026
4,947
Return on equity(%)
Jun 2022
12.9
Jun 2023
12.4
Jun 2024
14.5
Jun 2025
14.2
Jun 2026
13.8
Equity ratio(%)
Jun 2022
37.3
Jun 2023
38.3
Jun 2024
40.9
Jun 2025
41.8
Jun 2026
42
Earnings per share(JPY per share)
Jun 2022
145.615
Jun 2023
156.92
Jun 2024
104.105
Jun 2025
232.51
Jun 2026
258.51
Net assets per share(JPY per share)
Jun 2022
1,191.705
Jun 2023
1,337.17
Jun 2024
766.405
Jun 2025
1,752.3
Jun 2026
2,006
Dividend per share(JPY per share)
Jun 2022
12.5
Jun 2023
12.5
Jun 2024
12.75
Jun 2025
13
Jun 2026
13
Payout ratio(%)
Jun 2022
8.58
Jun 2023
7.97
Jun 2024
12.25
Jun 2025
5.59
Jun 2026
5.03
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.